特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
229565

ビタミンD検査の世界市場:2019年~2023年

Global Vitamin D Testing Market 2019-2023

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 132 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
ビタミンD検査の世界市場:2019年~2023年
出版日: 2019年07月12日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 132 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

ビタミンDは、骨と歯のミネラル化を調整するために血清カルシウムとリン酸濃度を維持するために必要です。2018年には、25-ヒドロキシビタミンD検査セグメントが大きな市場シェアを獲得しており、この傾向は予測期間中も続くと予想されます。ビタミンD欠乏症の罹患率の増加のような要因は、市場ポジションを維持するために25-ヒドロキシビタミンD検査セグメントで重要な役割を果たすでしょう。また、ビタミンDの重要性に対する意識の高まり、ビタミンD欠乏関連障害の増加、老年人口の増加などが成長要因となり、世界のビタミンD検査市場は、予測期間中に5%近くのCAGRで拡大する見込みです。しかし、製品のリコールは製造業者に課題を投げかけ、発展途上地域では意識の欠如と限られたヘルスケアサービス、そして標準的な規制検査ガイドラインの欠如などが測期間にわたるビタミンD検査産業の成長を妨げる可能性があります。

当レポートでは、世界のビタミンD検査市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年~2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 製品別比較:市場規模および予測(2018年~2023年)
  • 25-ヒドロキシビタミンD検査
  • 1,25-ジヒドロキシビタミンD検査
  • 市場機会:製品別

第7章 顧客情勢

第8章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション:エンドユーザー別

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年~2023年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第12章 市場動向

  • 感染症と自己免疫疾患の増加
  • ベンダーによる戦略的開発の増加
  • ベンダーによる革新的な製品提供

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH

第15章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第16章 TECHNAVIOについて

目次
Product Code: IRTNTR31719

About this market

Vitamin D is needed to maintain serum calcium and phosphate concentration to regularize the mineralization of bone and tooth. Technavio's vitamin D testing market analysis considers sales from both 25-hydroxyvitamin D testing and 1,25-dihydroxyvitamin D testing. Our analysis also considers the sales of vitamin D testing in Asia, Europe, North America, and ROW. In 2018, the 25-hydroxyvitamin D testing segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of vitamin D deficiency disorders will play a significant role in the 25-hydroxyvitamin D testing segment to maintain its market position. Also, our global vitamin D testing market report also looks at factors such as growing awareness on the importance of vitamin D, growing number of vitamin D deficiency-related disorders, and increasing geriatric population. However, product recalls posing challenge to the manufacturers, lack of awareness and limited healthcare services in developing regions, and lack of standard regulatory testing guidelines may hamper the growth of the vitamin D testing industry over the forecast period.

Overview

Growing number of vitamin D deficiency-related disorders

Rickets, a disease in which bone tissue does not properly mineralize, leading to soft bones and skeletal deformities in children is caused due to vitamin D deficiency. The deficiency in an adult causes mineralization problem in the skeleton, causing osteomalacia. Also, deficiency of vitamin D is related to increased risk of acquiring diabetes, immune system diseases, and neuropsychiatric disorder. The increasing prevalence of vitamin D deficiency-related disorders due to growing life expectancy will lead to the expansion of the global vitamin D testing market at a CAGR of almost 5% during the forecast period.

An increasing number of infections and autoimmune diseases

Vitamin D plays a key role in managing the immune system, as vitamin D receptor is expressed in all immune cells that include B cells, T cells, and antigen-presenting cells. These immunological cells can synthesize active vitamin D metabolites, thereby helping vitamin D to modulate the innate and adaptive immune responses. Vitamin D deficiency is linked with increased autoimmunity and susceptibility to infectious diseases caused by organisms such as bacteria, virus, fungi, and parasites. The increasing number of infections and autoimmune diseases is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global vitamin D testing market during the forecast period 2019-2023., view our report.

Competitive Landscape

With the presence of a few major players, the global vitamin D testing market is fairly concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vitamin D testing companies, that include Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., and Siemens Healthcare GmbH.

Also, the vitamin D testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • 25-hydroxyvitamin D testing - Market size and forecast 2018-2023
  • 1,25-dihydroxyvitamin D testing - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing number of infections and autoimmune diseases
  • Growing number of strategic developments by vendors
  • Innovative product offerings by vendors

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: -hydroxyvitamin D testing - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Parameters for 25-hydroxyvitamin serum concentrations
  • Exhibit 22: -hydroxyvitamin D testing - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: ,25-dihydroxyvitamin D testing - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: ,25-dihydroxyvitamin D testing - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global vitamin D testing market share by end-users 2018
  • Exhibit 28: Market share by geography 2018-2023 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Recommended dietary allowance for vitamin D by age and gender
  • Exhibit 32: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 38: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 39: Key leading countries
  • Exhibit 40: Market opportunity
  • Exhibit 41: Impact of drivers and challenges
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Abbott Laboratories - Vendor overview
  • Exhibit 48: Abbott Laboratories - Business segments
  • Exhibit 49: Abbott Laboratories - Organizational developments
  • Exhibit 50: Abbott Laboratories - Geographic focus
  • Exhibit 51: Abbott Laboratories - Segment focus
  • Exhibit 52: Abbott Laboratories - Key offerings
  • Exhibit 53: bioMerieux SA - Vendor overview
  • Exhibit 54: bioMerieux SA - Business segments
  • Exhibit 55: bioMerieux SA - Organizational developments
  • Exhibit 56: bioMerieux SA - Geographic focus
  • Exhibit 57: bioMerieux SA - Key offerings
  • Exhibit 58: Danaher Corp. - Vendor overview
  • Exhibit 59: Danaher Corp. - Business segments
  • Exhibit 60: Danaher Corp. - Organizational developments
  • Exhibit 61: Danaher Corp. - Geographic focus
  • Exhibit 62: Danaher Corp. - Segment focus
  • Exhibit 63: Danaher Corp. - Key offerings
  • Exhibit 64: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 65: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 66: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 67: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 68: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 69: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 70: Siemens Healthcare GmbH - Vendor overview
  • Exhibit 71: Siemens Healthcare GmbH - Business segments
  • Exhibit 72: Siemens Healthcare GmbH - Organizational developments
  • Exhibit 73: Siemens Healthcare GmbH - Geographic focus
  • Exhibit 74: Siemens Healthcare GmbH - Segment focus
  • Exhibit 75: Siemens Healthcare GmbH - Key offerings
  • Exhibit 76: Validation techniques employed for market sizing
  • Exhibit 77: Definition of market positioning of vendors
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.